CLLS - Cellectis S A Stock Trading

Cellectis S.A.(NASDAQ: CLLS) stock trading, description, contact, officers and directors.

About Cellectis S.A.

Not available

Stock Information

Cellectis S.A. Company Name:

CLLS Stock Symbol:

NASDAQ Market:

Get CLLS Alerts

News, Short Squeeze, Breakout and More Instantly...

CLLS - Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021

NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing company with clinical-stage immuno-oncology programs using allogeneic chimeric antigen receptor (CAR)-T cells and gene therapy programs for...
CLLS - Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

NEW YORK, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing platform company with clinical-stage immuno-oncology programs using allogeneic chimeric antigen receptor (CAR)-T cells and gene therapy pro...
CLLS - 7 Gene Editing Stocks Promising to Change our DNA

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In the 1980s, the field of genetics surged in popularity. At the time, I’m sure there were many articles promising investors that genetics stocks were on the cusp of spectacular gains. Investors who were looking for ...